HENLIUS CEO Zhu Jun on the 'First Principle' in Pharma: Daring to Tackle Challenges Others Avoid

Deep News15:05

At the 2026 Yabuli Forum Annual Meeting held from March 17 to 19 in Heilongjiang, HENLIUS CEO Zhu Jun delivered a speech. Zhu Jun noted that the company was selected last year as one of Forbes' 50 Most Innovative Companies, with only eight pharmaceutical firms making the list, including HENLIUS. He admitted, "Perhaps it's because much of what we do has a certain rebelliousness, yet it does not deviate from the first principle." He further explained that the so-called first principle means, first and foremost, regardless of the level of risk, focusing on whether the mission one sets out to achieve can solve problems that others may currently shy away from. Second, is artificial intelligence (AI). Zhu Jun stated that HENLIUS fully embraces AI to enhance work efficiency. The company now requires every executive to raise crayfish, with each crayfish developing differently, symbolizing the introduction of an additional tool in their work.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment